Product labeling accuracy and contamination analysis of commercially available cannabidiol product samples.
Ontology highlight
ABSTRACT: Background and objective: Commercially available cannabidiol (CBD) products are increasingly being used for medicinal purposes, including for the treatment of various neurological conditions, but there are growing concerns around adherence to quality control measures that protect consumers. This study was conducted to assess the purity and label accuracy of commercially available CBD products. Methods: Commercially available CBD products were chosen from the open stream of commerce in the United States based on formulations as a tincture, gummy, vape, or topical product. Cannabinoid concentrations were analyzed to verify label accuracy including "full spectrum," "broad spectrum," and "CBD isolate" claims on the product label. Analysis for the presence of contaminants included
SUBMITTER: Gidal BE
PROVIDER: S-EPMC10982813 | biostudies-literature | 2024
REPOSITORIES: biostudies-literature
ACCESS DATA